CTKB
Cytek Biosciences, Inc. NASDAQ$4.66
Mkt Cap $599.0M
52w Low $2.37
60.1% of range
52w High $6.18
50d MA $4.45
200d MA $4.44
P/E (TTM)
-8.9x
EV/EBITDA
-33.8x
P/B
1.7x
Debt/Equity
0.1x
ROE
-19.5%
P/FCF
-73.6x
RSI (14)
—
ATR (14)
—
Beta
1.28
50d MA
$4.45
200d MA
$4.44
Avg Volume
739.3K
About
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | -0.02 | -0.01 | +50.0% | 4.40 | -3.6% | +1.8% | +0.7% | +0.9% | +0.2% | -0.5% | — |
| Nov 5, 2025 | AMC | 0.01 | -0.01 | -200.0% | 4.01 | +6.5% | +13.2% | +15.2% | +18.5% | +19.5% | +20.0% | — |
| Aug 6, 2025 | AMC | -0.02 | 0.01 | +150.0% | 3.89 | +0.0% | +5.7% | +3.6% | -2.6% | +3.6% | +7.2% | — |
| May 8, 2025 | AMC | -0.04 | -0.09 | -125.0% | 3.79 | -18.2% | -22.7% | -20.3% | -21.4% | -28.0% | -29.3% | — |
| Feb 27, 2025 | AMC | 0.05 | 0.07 | +40.0% | 4.81 | -4.4% | -6.7% | -10.6% | -10.4% | -7.1% | -7.3% | — |
| Nov 5, 2024 | AMC | 0.00 | 0.01 | +168.0% | 5.44 | +9.9% | +36.0% | +32.7% | +29.6% | +31.4% | +29.4% | — |
| Aug 6, 2024 | AMC | -0.03 | -0.08 | -166.7% | 5.62 | +1.4% | -9.4% | -3.6% | -7.1% | -6.9% | -4.8% | — |
| May 8, 2024 | AMC | -0.05 | -0.05 | +0.0% | 6.27 | +1.3% | -1.1% | +0.5% | -1.4% | +0.5% | -2.7% | — |
| Mar 13, 2024 | AMC | 0.03 | 0.07 | +133.3% | 6.74 | +0.1% | +1.2% | +3.1% | +0.9% | -0.6% | -0.6% | — |
| Nov 7, 2023 | AMC | -0.33 | 0.01 | +103.0% | 4.45 | -14.6% | +12.4% | +7.3% | +10.1% | +11.5% | +22.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8 | TD Cowen | Maintains | Buy → Buy | — | $5.50 | $5.49 | -0.2% | -1.3% | -0.9% | +5.5% | +3.6% | +1.1% |
| Nov 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.75 | $4.69 | -1.3% | +0.8% | +1.3% | -3.8% | +15.8% | +11.4% |
| May 28 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $2.57 | $2.55 | -0.8% | -3.1% | +0.8% | +7.8% | +10.1% | +10.9% |
| May 12 | Goldman Sachs | Maintains | Sell → Sell | — | $2.93 | $3.06 | +4.4% | +3.1% | +1.7% | -6.8% | -8.5% | -8.9% |
| Mar 19 | Stephens & Co. | Maintains | Overweight → Overweight | — | $4.24 | $4.20 | -0.9% | -0.5% | -4.2% | -0.9% | -0.5% | -3.3% |
| Mar 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.30 | $4.22 | -1.9% | +0.2% | +4.0% | +3.7% | +5.3% | +1.4% |
| Nov 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $7.05 | $6.99 | -0.9% | +1.4% | -0.1% | -3.8% | -8.9% | -15.6% |
| Aug 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.23 | $5.29 | +1.1% | +2.3% | +1.3% | +3.4% | +5.0% | +5.7% |
| May 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $6.30 | $6.30 | +0.0% | -1.9% | +0.0% | -3.2% | -1.9% | -3.2% |
| Mar 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $8.14 | $8.08 | -0.7% | -13.1% | -12.0% | -12.5% | -11.3% | -15.7% |
Recent Filings
Data updated apr 25, 2026 3:41am
· Source: massive.com